Market Summary: In 2022, the global market size for cystic fibrosis drugs reached USD 11.00 billion, with a projected compound annual growth rate (CAGR) of 24.5% during the forecast period. Advances in therapeutic technologies and new treatment options are the primary drivers of the market’s revenue growth. The increasing demand for bronchodilator drugs, driven by […]
